| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |